Guy Anderson - Theralase Technologies Independent Director
| TLTFF Stock | USD 0.12 0.01 7.69% |
Director
Mr. Guy J. Anderson, BA, CFP, CIM, FMA, FCSI, MBA, was appointed as Independent Director of Theralase Technologies Inc., effective February 1, 2013 since 2013.
| Tenure | 11 years |
| Phone | 416 699 5273 |
| Web | https://www.theralase.com |
Theralase Technologies Management Efficiency
The company has return on total asset (ROA) of (0.5866) % which means that it has lost $0.5866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.131) %, meaning that it generated substantial loss on money invested by shareholders. Theralase Technologies' management efficiency ratios could be used to measure how well Theralase Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Harald Ruf | Orthopediatrics Corp | 64 | |
| Guy Jordan | Orthofix Medical | 65 | |
| Filippo Passerini | Integer Holdings Corp | 63 | |
| Susan Knight | SurModics | 63 | |
| Fred Hite | Orthopediatrics Corp | 56 | |
| Raymond Land | Anika Therapeutics | 72 | |
| Luke Faulstick | Orthofix Medical | 54 | |
| Serge Novovich | Iradimed Co | 81 | |
| Stan Erickson | Electromed | 66 | |
| Cheryl Capps | Integer Holdings Corp | 59 | |
| Oscar Moralez | Orthopediatrics Corp | 52 | |
| Jose Bedoya | SurModics | 61 | |
| Hugh Morrison | LivaNova PLC | 70 | |
| Maria Sainz | Orthofix Medical | 51 | |
| Marie Infante | Orthopediatrics Corp | 68 | |
| Sheila Antrum | Integer Holdings Corp | 62 | |
| Peter Soderberg | Integer Holdings Corp | 71 | |
| William Eckles | Electromed | 42 | |
| Samuel Riccitelli | Orthopediatrics Corp | 59 | |
| Anthony Martin | Orthofix Medical | 59 | |
| Ronald Kalich | SurModics | 70 | |
Management Performance
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 |
Theralase Technologies Leadership Team
Elected by the shareholders, the Theralase Technologies' board of directors comprises two types of representatives: Theralase Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theralase. The board's role is to monitor Theralase Technologies' management team and ensure that shareholders' interests are well served. Theralase Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theralase Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randall Bruder, Independent Director | ||
| Lori Leach, Marketing Consultant | ||
| Guy Anderson, Independent Director | ||
| Terry DVM, Equine Consultant | ||
| Michael Borovec, Director of Investor Relations | ||
| Kristina Hachey, CFO | ||
| Roger DumoulinWhite, President CEO, Director | ||
| David BA, Pres Division | ||
| Matthew Perraton, Director | ||
| DSc MD, Chief CEO | ||
| Vaughn Wyant, Marketing Consultant | ||
| Kristina CPA, CFO Director |
Theralase Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Theralase Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | (5.50) % | |||
| Current Valuation | 51.77 M | |||
| Shares Outstanding | 216.5 M | |||
| Shares Owned By Insiders | 2.56 % | |||
| Price To Earning | (9.16) X | |||
| Price To Book | 20.01 X | |||
| Price To Sales | 52.92 X | |||
| Revenue | 780.64 K |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Theralase Technologies information on this page should be used as a complementary analysis to other Theralase Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Theralase OTC Stock analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |